| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 10/05/2024 | 22:01 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ARAY | Accuray Incorporated |
| 08/05/2024 | 22:22 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ARAY | Accuray Incorporated |
| 01/05/2024 | 22:06 | PR Newswire (US) | Accuray Reports Fiscal 2024 Third Quarter Financial Results | NASDAQ:ARAY | Accuray Incorporated |
| 25/04/2024 | 13:35 | PR Newswire (US) | Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024 | NASDAQ:ARAY | Accuray Incorporated |
| 18/04/2024 | 13:35 | PR Newswire (US) | Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland | NASDAQ:ARAY | Accuray Incorporated |
| 17/04/2024 | 22:05 | PR Newswire (US) | Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024 | NASDAQ:ARAY | Accuray Incorporated |
| 26/03/2024 | 12:35 | PR Newswire (US) | New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System | NASDAQ:ARAY | Accuray Incorporated |
| 05/03/2024 | 22:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ARAY | Accuray Incorporated |
| 04/03/2024 | 22:30 | PR Newswire (US) | Accuray Incorporated to Speak at 36th Annual Roth Conference | NASDAQ:ARAY | Accuray Incorporated |
| 27/02/2024 | 23:30 | PR Newswire (US) | Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference | NASDAQ:ARAY | Accuray Incorporated |
| 13/02/2024 | 17:19 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:ARAY | Accuray Incorporated |
| 13/02/2024 | 13:35 | PR Newswire (US) | Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System | NASDAQ:ARAY | Accuray Incorporated |
| 05/02/2024 | 23:30 | PR Newswire (US) | Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference | NASDAQ:ARAY | Accuray Incorporated |
| 31/01/2024 | 22:06 | PR Newswire (US) | Accuray Reports Fiscal 2024 Second Quarter Financial Results | NASDAQ:ARAY | Accuray Incorporated |
| 25/01/2024 | 13:35 | PR Newswire (US) | Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions | NASDAQ:ARAY | Accuray Incorporated |
| 16/01/2024 | 23:30 | PR Newswire (US) | Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024 | NASDAQ:ARAY | Accuray Incorporated |
| 05/12/2023 | 13:30 | PR Newswire (US) | Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System | NASDAQ:ARAY | Accuray Incorporated |
| 30/11/2023 | 22:01 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:ARAY | Accuray Incorporated |
| 07/11/2023 | 22:07 | PR Newswire (US) | Accuray Reports Fiscal 2024 First Quarter Financial Results | NASDAQ:ARAY | Accuray Incorporated |
| 31/10/2023 | 12:30 | PR Newswire (US) | Accuray to Participate in the 14th Annual Jefferies London Healthcare Conference | NASDAQ:ARAY | Accuray Incorporated |
| 26/10/2023 | 22:05 | PR Newswire (US) | Accuray to Report First Quarter Fiscal 2024 Financial Results on November 7, 2023 | NASDAQ:ARAY | Accuray Incorporated |
| 03/10/2023 | 22:05 | PR Newswire (US) | Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China's National Medical Products Administration | NASDAQ:ARAY | Accuray Incorporated |
| 02/10/2023 | 13:35 | PR Newswire (US) | Accuray and Limbus AI Unveil Online Adaptive Therapy Solution for the Radixact® System at American Society for Radiation Oncology (ASTRO) Annual Meeting | NASDAQ:ARAY | Accuray Incorporated |
| 29/09/2023 | 22:11 | Edgar (US Regulatory) | Form ARS - Annual Report to Security Holders | NASDAQ:ARAY | Accuray Incorporated |
| 29/09/2023 | 22:08 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:ARAY | Accuray Incorporated |
| 29/09/2023 | 22:05 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:ARAY | Accuray Incorporated |
| 18/09/2023 | 13:35 | PR Newswire (US) | Accuray Opens New Global Training Center at Madison, WI Headquarters to Advance Radiotherapy Treatment Techniques Amid Growing Demand for Precision Cancer Care | NASDAQ:ARAY | Accuray Incorporated |
| 14/09/2023 | 13:30 | PR Newswire (US) | Accuray to Host Investor Day at ASTRO on October 3, 2023 | NASDAQ:ARAY | Accuray Incorporated |
| 07/09/2023 | 22:56 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:ARAY | Accuray Incorporated |
| 10/08/2023 | 02:00 | PR Newswire (US) | Accuray Receives FDA Clearance for VitalHold™ on the Radixact® System; Breast Cancer Treatment Option Will Also Be Available in the EU Market | NASDAQ:ARAY | Accuray Incorporated |